Always inform PlexusDx and your prescribing physician of all current medications to ensure safe, coordinated care
CrossRef The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis Chen Li, Jie Luo, Mingyan Jiang, Keke Wang Frontiers in Pharmacology.2022;[Epub] CrossRef Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62) Hwi Seung Kim, Woo Je Lee Diabetes & Metabolism Journal.2022
Make a habit of changing your passwords every three months and use a password manager to generate and store complex passwords
Be alert for symptoms of hyperkalemia (high potassium levels), such as muscle weakness, irregular heartbeat, confusion, trouble breathing, or numbness and tingling in your hands or feet
Understanding how each peptide works helps you make informed choices aligned with your health goals, fostering confidence in your decisions
Patients should generally be established on their current Wegovy injection dose for at least 4 weeks and be tolerating treatment well before considering a switch to Wegovy tablets